Nancy J. Hutson, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 25,732 shares at $8.04 ($207K) on 2023-06-14, disclosed to the SEC on 2023-06-15.
Seasonal sale ($207k) by Director — this insider has traded BCRX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.04 | 12,866 | $103K | 50.0% |
| 2 | $8.04 | 12,866 | $103K | 50.0% |
| Total | $8.04 avg | 25,732 | $207K | 100% |
| Filing → |
| CLSD | BUY | 2023-10-04 | $9K | — | Filing → |
| CLSD | BUY | 2022-11-21 | $40K | — | Filing → |
| BCRX | SELL | 2021-10-19 | $1.6M | — | Filing → |